Search details
1.
PARP-Targeted Radiotheranostics with Auger Electrons: An Updated Overview.
Curr Issues Mol Biol
; 46(4): 3039-3049, 2024 Mar 31.
Article
in English
| MEDLINE | ID: mdl-38666920
2.
The ß3 adrenoceptor in proliferative retinopathies: "Cinderella" steps out of its family shadow.
Pharmacol Res
; 190: 106713, 2023 04.
Article
in English
| MEDLINE | ID: mdl-36863427
3.
ß-Adrenoceptors in Cancer: Old Players and New Perspectives.
Handb Exp Pharmacol
; 2023 Nov 21.
Article
in English
| MEDLINE | ID: mdl-37982890
4.
NEO-SAFE: a clinical model for patients and healthcare personnel safety in primary level hospitals.
Int J Qual Health Care
; 35(3)2023 Jul 05.
Article
in English
| MEDLINE | ID: mdl-37405853
5.
Performance Analysis of Six Semi-Automated Tumour Delineation Methods on [18F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG PET/CT) in Patients with Head and Neck Cancer.
Sensors (Basel)
; 23(18)2023 Sep 18.
Article
in English
| MEDLINE | ID: mdl-37766009
6.
Fibroblast Activation Protein Inhibitor (FAPI)-Based Theranostics-Where We Are at and Where We Are Heading: A Systematic Review.
Int J Mol Sci
; 24(4)2023 Feb 15.
Article
in English
| MEDLINE | ID: mdl-36835275
7.
Fetal Oxygenation from the 23rd to the 36th Week of Gestation Evaluated through the Umbilical Cord Blood Gas Analysis.
Int J Mol Sci
; 24(15)2023 Aug 06.
Article
in English
| MEDLINE | ID: mdl-37569862
8.
ß3-Adrenoceptor, a novel player in the round-trip from neonatal diseases to cancer: Suggestive clues from embryo.
Med Res Rev
; 42(3): 1179-1201, 2022 05.
Article
in English
| MEDLINE | ID: mdl-34967048
9.
Head-to-Head Comparison between Peptide-Based Radiopharmaceutical for PET and SPECT in the Evaluation of Neuroendocrine Tumors: A Systematic Review.
Curr Issues Mol Biol
; 44(11): 5516-5530, 2022 Nov 07.
Article
in English
| MEDLINE | ID: mdl-36354685
10.
Infantile hemangiomas ß3-adrenoceptor overexpression is associated with nonresponse to propranolol.
Pediatr Res
; 91(1): 163-170, 2022 01.
Article
in English
| MEDLINE | ID: mdl-33654276
11.
Theragnostics in primary and secondary liver tumors: the need for a personalized approach.
Q J Nucl Med Mol Imaging
; 65(4): 353-370, 2021 Dec.
Article
in English
| MEDLINE | ID: mdl-34881847
12.
Fully Renewable Non-Isocyanate Polyurethanes via the Lossen Rearrangement.
Macromol Rapid Commun
; 42(3): e2000440, 2021 Feb.
Article
in English
| MEDLINE | ID: mdl-32935889
13.
Prognostic and Theranostic Applications of Positron Emission Tomography for a Personalized Approach to Metastatic Castration-Resistant Prostate Cancer.
Int J Mol Sci
; 22(6)2021 Mar 16.
Article
in English
| MEDLINE | ID: mdl-33809749
14.
Theragnostic Aspects and Radioimmunotherapy in Pediatric Tumors.
Int J Mol Sci
; 21(11)2020 May 28.
Article
in English
| MEDLINE | ID: mdl-32481723
15.
Positron Emission Tomography (PET) and Neuroimaging in the Personalized Approach to Neurodegenerative Causes of Dementia.
Int J Mol Sci
; 21(20)2020 Oct 11.
Article
in English
| MEDLINE | ID: mdl-33050556
16.
ß3-Adrenoreceptor Blockade Reduces Hypoxic Myeloid Leukemic Cells Survival and Chemoresistance.
Int J Mol Sci
; 21(12)2020 Jun 12.
Article
in English
| MEDLINE | ID: mdl-32545695
17.
ß3-Adrenoreceptor Blockade Induces Stem Cells Differentiation in Melanoma Microenvironment.
Int J Mol Sci
; 21(4)2020 Feb 20.
Article
in English
| MEDLINE | ID: mdl-32093135
18.
Something still missing in molecular imaging: CXCR2 axis in prostate cancer.
Eur J Nucl Med Mol Imaging
; 51(3): 615-617, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-37935994
19.
Structured reporting in prostate cancer: the revolution of quality in nuclear medicine scan interpretation.
Eur Radiol
; 34(2): 1155-1156, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-38123691
20.
ß3-Adrenoreceptor Activity Limits Apigenin Efficacy in Ewing Sarcoma Cells: A Dual Approach to Prevent Cell Survival.
Int J Mol Sci
; 20(9)2019 Apr 30.
Article
in English
| MEDLINE | ID: mdl-31052299